Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics Adds Two New Board Directors
Published in Drug Law Weekly, May 8th, 2007
Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) announced that Jane L. Delgado, Ph. D., M.S., and Mark Sotir have been elected to join the Board of Directors and that long-time Director, William C. Pate, currently chief investment officer, Equity Group Investments, L.L.C. (EGI), has resigned from the Board, effective April 19. As a result of these changes, Adams' Board will have nine directors, the maximum number permitted.
Commenting on the Board composition changes, Michael J. Valentino, president and CEO said, "We are pleased to have Dr. Jane Delgado and Mark R. Sotir join our Board of Directors. We look forward to benefiting from their individual areas of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-05-08)
More Articles from Drug Law Weekly
- Allergies
Allergy & Asthma Network Mothers of Asthmatics Exposes Potentially Dangerous Asthma Medications - Arthritis
Former Building Cleaner Confronts J&J About Access to Health Care, Drugs - Biotech Business
Spherix Signs Letter of Intent for the Sale of Its Information Subsidiary - Drug Delivery
OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis - Drug Development
Express Scripts' Workers' Compensation Program Increases Use of Generic Drugs - Drug Development
Recent studies from National Board of Forensic Medicine add new data to drug development - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
